ИСТИНА

• Охват: Международная
• Даты проведения: 27-29 октября 2018
• Место проведения: Кельн, Германия
• Число участников: 100
• Число иностранных участников: 100
• Число участников из МГУ: 4
• Веб-сайт: https://www.hodgkinsymposium.org/
• Описание конференции:

  FOLLOW-UP CARE OF HODGKIN LYMPHOMA SURVIVORS IS IMPORTANT Most patients with Hodgkin Lymphoma (HL) achieve long-term remission after adequate first-line treatment. Nonetheless, follow-up care is important for several reasons. Firstly, the risk for HL recurrence appears to be increased for 20 years after initial diagnosis (Bröckelmann et al., J Clin Oncol, 2017). Secondly, a relevant proportion of patients develop treatment-related late effects including second malignancies. The recently published 10-year follow-up analysis of the randomized GHSG HD15 study for patients with advanced HL revealed a second malignancy rate of 7% (Engert et al., Hemasphere, 2017). Coronary heart disease and fatigue represent other late sequelae causing relevant morbidity and mortality (van Nimwegen et al., J Clin Oncol, 2016; Kreissl et al., Lancet Oncol, 2016). Given the need of post-treatment surveillance in HL patients, follow-up and survivorship aspects will represent a major focus of ISHL11.

• Добавил в систему: Рупчев Георгий Евгеньевич

Доклады:

• 2018 COGNITIVE IMPAIRMENTS IN PATIENTS WITH HODGKIN'S LYMPHOMA (Стендовый)
• Авторы: Vinokurova E.G., Marchenko A.A., Khrushchev S.O., Moiseeva T.N., Rupchev G.E., Vybornykh D.E., Olexenko L.V.